- Endometrial hyperplasia
- Risk factors
- Cytological atypia
- Diagnosis
- Surveillance
- Histological examination
- Endometrial sampling
- Hysteroscopy
- Treatment options
- Progestogens
- Surgical management
- Total hysterectomy
- LNG-IUS
- Adjuvant treatment for breast cancer
- Endometrial polyp
- Endometrial surveillance
- WHO classification
- Regression
- Obesity
- HRT
- Biomarkers
- Progression to cancer
- Levonorgestrel-releasing intrauterine system
- Outpatient endometrial biopsy
- Transvaginal ultrasound
- Endometrial ablation
- Follow-up
- Fertility preservation
- Assisted reproduction
- PCOS
- Tamoxifen
- Ovarian removal
- Endometrial thickness
- Endometrial cancer
- Hyperplasia in postmenopausal women
- Bariatric surgery
- Endometrial pathology
- Hormone replacement therapy
- Ovarian cysts
- Granulosa cell tumor
- Comparative studies
- Endometrial sampling techniques
- Long-term consequences
- Mortality
- IVF-ET outcomes
- Hormone therapy
- Aromatase inhibitors
- Resectoscopic treatment
- Guidelines Committee
- Review process